Skip to search formSkip to main contentSkip to account menu

Bluebird Bio

Known as: Blue Bird Biotec 
A clinical-stage biotechnology company using gene therapy, cancer immunotherapy, and gene editing to treat and cure genetic diseases and cancer.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Non-graft-vs.-host disease (non-GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT… 
2018
2018
Abstract Protein engineering is used to generate novel protein folds and assemblages, to impart new properties and functions onto… 
Highly Cited
2018
Highly Cited
2018
Introduction: Immunomodulatory chimeric antigen receptor (CAR) T cell therapy directed against B-cell maturation antigen… 
2018
2018
Background We reported durable responses to CD19-specific chimeric antigen receptor-modified T-cell therapy (JCAR014) in… 
2018
2018
Autologous gene therapy (GT) for beta-hemoglobinopathies has demonstrated encouraging early safety and efficacy using… 
2018
2018
Background β-globin gene transfer has the potential for substantial clinical benefit in patients with sickle cell disease… 
Review
2016
Review
2016
Gene editing is a rapidly developing area of biotechnology in which the nucleotide sequence of the genome of living cells is… 
Highly Cited
2016
Highly Cited
2016
β-globin gene transfer into hematopoietic stem cells (HSCs) has the potential to reduce or eliminate the symptoms and long-term… 
Highly Cited
2015
Highly Cited
2015
A previously published clinical trial demonstrated the benefit of autologous CD34+ cells transduced with a self-inactivating… 
Highly Cited
2015
Highly Cited
2015
  • C. Morrison
  • Nature Biotechnology
  • 2015
  • Corpus ID: 205266596
an annuity model that spreads that payment over a number of years to lessen the costdensity burden on payers; and a pay…